Hepatic steatosis in chronic hepatitis C virus infection: Prevalence and clinical correlation

被引:132
|
作者
Hwang, SJ
Luo, JC
Chu, CW
Lai, CR
Lu, CL
Tsay, SH
Wu, JC
Chang, FY
Lee, SD
机构
[1] Natl Yang Ming Univ, Sch Med, Vet Gen Hosp, Dept Med,Div Gastroenterol, Taipei 11217, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Vet Gen Hosp, Dept Pathol, Taipei 11217, Taiwan
关键词
chronic hepatitis C; hepatic fibrosis; hepatic steatosis; hepatitis C virus genotype; hepatitis C virus RNA; histological activity index; obesity; serum triglyceride;
D O I
10.1046/j.1440-1746.2001.02407.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Hepatic steatosis is a histological characteristic in patients with chronic hepatitis C virus (HCV) infection. The aim of this study was to evaluate the prevalence of hepatic steatosis in Chinese patients with chronic hepatitis C, and to look for possible correlation with various histopathological changes and to look for possible correlation with various clinical and pathologic variables. Methods: One hundred and six patients were enrolled, and patients with alcoholism or diabetes mellitus were excluded. Clinical, biochemical and virologic data, including HCV genotype and serum HCV-RNA titer and histological findings, were compared between patients with and without hepatic steatosis. Results: Fifty-five (52%) of the 106 patients with chronic hepatitis C had hepatic steatosis. Patients with hepatic steatosis had significantly higher mean serum levels of triglyceride and gamma -glutamyl transpeptidase, higher body mass index, and a higher incidence of obesity compared with patients without hepatic steatosis. No significant differences in serum HCV-RNA titer and HCV genotype or the response to interferon therapy were noted between the two groups. Histological analysis showed patients with hepatic steatosis had a significantly higher mean fibrotic score than patients without hepatic steatosis (1.9 +/- 1.2 vs 1.3 +/- 1.0; P = 0.016). There were no significant differences in the severity of necroinflammation, the presence of lymphoid aggregation/follicle or bile duct damage between the two groups. Multivariate logistic regression analysis showed that independent predictors associated with hepatic steatosis were obesity or a histology fibrotic score of greater than or equal to 2. Conclusion: It was found that 52% of Chinese patients with chronic hepatitis C had hepatic steatosis. Patients with hepatic steatosis were more frequently obese and had more severe hepatic fibrosis. (C) 2001 Blackwell Science Asia Pty Ltd.
引用
收藏
页码:190 / 195
页数:6
相关论文
共 50 条
  • [11] Distribution of hepatitis C virus genotypes, hepatic steatosis and their correlation with clinical and virological factors in Pakistan
    Safi, Sher Zaman
    Badshah, Yasmin
    Waheed, Yasir
    Fatima, Kaneez
    Tahir, Sadia
    Shinwari, Alamgir
    Qadri, Ishtiaq
    ASIAN BIOMEDICINE, 2010, 4 (02) : 253 - 262
  • [12] The impact of hepatic steatosis on the natural history of chronic hepatitis C infection
    Cross, T. J. S.
    Quaglia, A.
    Hughes, S.
    Joshi, D.
    Harrison, P. M.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (07) : 492 - 499
  • [13] Prevalence and significance of hepatic steatosis in hepatitis C
    Vario, A
    Pistis, R
    Boccato, S
    Ferrari, A
    Alberti, A
    JOURNAL OF HEPATOLOGY, 2003, 38 : 179 - 180
  • [14] Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis
    Wang, Chia-Chi
    Hsu, Ching-Sheng
    Liu, Chun-Jen
    Kao, Jia-Horng
    Chen, Ding-Shinn
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (05) : 779 - 782
  • [15] Prevalence and predictors of steatosis in patients with chronic hepatitis C (HCV) infection
    Nachnani, Jagdish S.
    Laya, Alexandra
    Sadeddin, Esmat
    Smith, Owen J.
    Alba, Laura M.
    Clarkston, Wendell K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S223 - S223
  • [16] Hepatic steatosis in patients with chronic hepatitis C virus infection - Another risk factor for hepatocellular carcinoma?
    Zhu, AX
    Chung, RT
    CANCER, 2003, 97 (12) : 2948 - 2950
  • [17] HEPATIC LIDOCAINE METABOLISM IN CHRONIC HEPATITIS-C VIRUS HEPATITIS WITH OR WITHOUT STEATOSIS
    TALIANI, G
    DUCA, F
    LECCE, R
    LIVOLI, D
    PASQUAZZI, C
    DEBAC, C
    HEPATOLOGY, 1995, 21 (06) : 1760 - 1761
  • [18] Impact of ethnicity and antioxidant use on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection
    Gaslightwala, I
    Bini, EJ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S115 - S115
  • [19] THE IMPACT OF HEPATIC STEATOSIS ON THE NATURAL HISTORY OF CHRONIC HEPATITIS C INFECTION (CHC) INFECTION
    Cross, Timothy J.
    Quaglia, Alberto
    Hughes, Sarah
    Joshi, Deepak
    Harrison, Phillip M.
    HEPATOLOGY, 2008, 48 (04) : 1097A - 1098A
  • [20] Iron, hepatitis C virus and hepatic steatosis
    Herruzo, JAS
    Solís-Muñoz, P
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (12) : 809 - 814